Last edition
News about Logistics & Distribution
CDSCO declares 44 drug samples as not of standard, one as misbranded in July
The Central Drugs Standard Control Organisation (CDSCO) has declared 44 drug samples out of 1028 it has tested as not of standard quality, during the month of July, 2021. Of the samples tested, 983 were declared as of standard quality
Logistics & Distribution | 23/08/2021 | By Darshana | 335
The Drugs Controller General (India) has classified 135 medical devices related to ophthalmology under the provisions of Medical Devices Rules, 2017. In another notice, it has also classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules
Logistics & Distribution | 11/08/2021 | By Darshana | 190
Abbott launches Panbio COVID-19 Antigen Self-Test in India
Abbott has launched Panbio COVID-19 Antigen Self-Test for detecting SARS-CoV-2 virus in adults and children with or without symptoms. In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases
Logistics & Distribution | 13/07/2021 | By Darshana | 250
Optima announces new laboratory, scheduling and resource management system
Optima's algorithm combines all information collected in the system setting and the historical data generated, to provide a scheduling proposal on the best way to coordinate the human and instruments resources to execute the tasks requested and respond to the laboratory's demand.
Logistics & Distribution | 01/07/2021 | By Darshana | 200
Haffkine Biopharma to produce 22.8 crore Covaxin doses per annum
Haffkine Biopharma, a Maharashtra state PSU proposed to produce 22.8 crore Covaxin doses per annum under technology transfer arrangement with Bharat Biotech. The production will take place at the Parel complex of the company in Mumbai
Logistics & Distribution | 02/06/2021 | By Darshana | 206
Jenburkt Pharmaceuticals second in India to launch Favipiravir to fight COVID-19
Jenburkt Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name Favivent) for the treatment of mild to moderate COVID-19 symptoms at a price of Rs. 39/- per tablet
Logistics & Distribution | 24/07/2020 | By Darshana | 442
Roche today presented two-year data from Part 1 of its pivotal SUNFISH trial in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA) at the virtual Cure SMA Annual Conference, 8-12 June, 2020
Logistics & Distribution | 15/06/2020 | By Darshana | 436
These data confirm the longer-term efficacy of Alecensa already demonstrated across three phase III clinical trials. Full findings were presented at the ASCO20 Virtual Scientific Programme, on 29 May 2020
Logistics & Distribution | 01/06/2020 | By Darshana | 395
GSK Pharma to discontinue manufacture & supply of Zinetac tablets in India
GlaxoSmithKline Pharmaceuticals announced that the company has decided to discontinue the manufacture and supply of Zinetac tablets, used to treat and prevent heartburn
Logistics & Distribution | 22/05/2020 | By Darshana | 560
Cipla files ANDA for generic version of GSK's Advair Diskus to US FDA
Cipla Limited announced its submission of an Abbreviated New Drug Application (ANDA) for fluticasone propionate and salmeterol inhalation powder (100/50 mcg, 250/50 mcg and 500/50 mcg) to the United States Food and Drug Administration (FDA)
Logistics & Distribution | 20/05/2020 | By Darshana | 449
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy